Results 171 to 180 of about 54,068 (228)

Pioglitazone as a Possible Treatment for <i>Ataxia-Telangiectasia</i>. [PDF]

Biomolecules
Shackelford R.
europepmc   +1 more source

Ataxia telangiectasia in a Bahraini child treated with intensive physiotherapy: A case report. [PDF]

Hong Kong Physiother J
Razzaqi F, Albastaki A, Sinan I.
europepmc   +1 more source

Phase 1 clinical trial of the ataxia telangiectasia and Rad3-related inhibitor berzosertib with irinotecan in patients with advanced solid tumors (ETCTN 9938). [PDF]

Cancer
Villaruz LC, Jin J, Wang H, Lee JJ, Luke JJ, Rhee JC, Waqar SN, Shapiro GI, Cleary J, Davar D, Burns TF, Verma R, Amin M, Appleman L, Ciombor KK, Davis EJ, Riess JW, Dees EC, Kim EJ, Cardin D, Guo J, Christner SM, Deppas J, Parise AM, Schmitz JC, Guerrouahen BS, Suchko M, Contreras A, Li L, Ferry-Galow KV, Chang TC, Jiwani S, Bakkenist CJ, Chu E, Gore SD, Beumer JH.   +35 more
europepmc   +1 more source

Prevalence and outcomes of cancer and treatment-associated toxicities for patients with ataxia telangiectasia. [PDF]

J Allergy Clin Immunol
Magnarelli A, Liu Q, Wang F, Peng XP, Wright J, Oak N, Natale V, Rothblum-Oviatt C, Lefton-Greif MA, McGrath-Morrow S, Crawford TO, Ehrhardt MJ, Lederman HM, Sharma R.   +13 more
europepmc   +1 more source

Novel pathogenic ATM mutation with ataxia-telangiectasia in a Chinese family. [PDF]

Front Genet
Zhou Q, Chen M, Tao E.
europepmc   +1 more source

Is high AFP associated with liver diseases in ataxia-telangiectasia and ataxia-oculomotor apraxia? [PDF]

Hepatol Forum
Ismayilov R, Ozum T, Ersal E, Israfilov S, Abdurrahimli N, Cakmakli GY, Elibol B, Balaban HY.   +7 more
europepmc   +1 more source

Targeting Ataxia Telangiectasia-Mutated and Rad3-Related for Anaplastic Thyroid Cancer. [PDF]

Cancers (Basel)
Lin SF, Hsueh C, Chen WY, Chou TC, Wong RJ.   +4 more
europepmc   +1 more source

ATM Expression and Activation in Ataxia Telangiectasia Patients with and without Class Switch Recombination Defects. [PDF]

J Clin Immunol
Salami F, Shad TM, Fathi N, Mojtahedi H, Esmaeili M, Shahkarami S, Afrakoti LGMP, Amirifar P, Delavari S, Nosrati H, Razavi A, Ranjouri MR, Yousefpour M, Esfahani ZH, Azizi G, Ashrafi M, Rezaei N, Yazdani R, Abolhassani H.   +18 more
europepmc   +1 more source

Population Pharmacokinetic Modeling and Pediatric Exposure of Dexamethasone Sodium Phosphate Encapsulated in Erythrocytes (eDSP) Administered Monthly for Treatment of Neurological Symptoms of Patients With Ataxia Telangiectasia. [PDF]

CPT Pharmacometrics Syst Pharmacol
Ozdin D, Kheibarshekan L, Mambrini G, Mambrini G, Tremblay PO.   +4 more
europepmc   +1 more source

PARP inhibitor BMN673 triggers PARylation-mediated ATF4-GDF15 pathway to drive autophagy and ferroptosis in ataxia telangiectasia mutated gene-deficient colorectal cancer cells. [PDF]

Mol Biomed
Xiang J, Xu J, Fan H, Chen Q, Lu Y, Wan X, Jiang Y, Zhang X, Zhang C, Liu Q, Ding D, Lei Y.   +11 more
europepmc   +1 more source